Microbot shares are trading higher Monday after the company received FDA approval to proceed with its human clinical trial. Microbot says the study will be conducted in the U.S., and it has already ...
Microbot Medical (NASDAQ:MBOT) just reported results for the second quarter of 2024. Microbot Medical reported earnings per share of -17 cents. This met the analyst estimate for EPS of -17 cents. The ...
Microbot Medical Inc. MBOT recently announced that it has submitted a 510(k) premarket notification to the FDA for its LIBERTY system. The 510(k) submission follows the successful completion of its ...
Pre-clinical medical device company, Microbot Medical (NASDAQ:MBOT) stock price is down 14%, enters agreement for the purchase and sale of ~624K shares at a purchase price of $3.25 per share. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback